The Tool Desk
Outbyte PC Repair FREERepair Windows errors before they cause bigger problemsFix Now →Outbyte Driver Updater FREEFix the driver behind crashes, sound loss and screen glitchesFind Drivers →Short answer: A QMS is the organization’s quality system; an eQMS is software used to manage parts of that system. “QMS software” is often another name for eQMS, not a separate regulatory category. Whether your company needs a particular system depends on what it makes or does, which rules or certification criteria apply, and how it manages quality—not simply on whether it buys software.
QMS, eQMS and QMS software: what is the difference?
A quality management system (QMS) is the framework of processes, responsibilities and records an organization uses to plan, control and improve quality. It includes people and procedures as well as records of activities such as training, design changes, complaints, nonconformities and corrective actions.
| Term | What it means | What it does not mean |
|---|---|---|
| QMS | The organization’s quality framework: responsibilities, processes, procedures and evidence that those processes were followed. | It is not necessarily a software product. |
| eQMS | Electronic QMS software used to execute, route, store or document some quality processes and records. | It does not create a complete or compliant quality system by itself. |
| QMS software | Usually a general term for software that supports QMS activities; in many product descriptions it means eQMS. | The term alone does not establish which processes, regulatory requirements or controls are covered. |
FDA describes its QMSR as requirements manufacturers must establish and follow to help ensure products consistently meet applicable requirements and specifications. The regulation addresses the organization’s system, not a particular software purchase. FDA’s QMSR overview explains the scope and requirements.
Does every digital health company need an eQMS?
No single answer applies to all companies described as “digital health.” A manufacturer of a finished medical device, a software-as-a-medical-device developer, a clinical software vendor and a health IT developer seeking certification may have different regulatory or certification obligations. First determine the company’s role, products, intended uses, markets and applicable requirements. Then decide which quality processes and records need a software-supported workflow.
Quick wins for a faster PC:
Fix the driver behind crashes, sound loss and screen glitchesFind Drivers →Repair Windows errors before they cause bigger problemsFix Now →#1 Best Overall
- Finished medical-device manufacturers: FDA’s QMSR applies to finished device manufacturers intending to commercially distribute medical devices, including certain accessories considered finished devices.
- Software developers: Whether a software product is a medical device and what requirements apply depends on its intended use and regulatory status. The label “digital health” alone does not settle that question.
- Health IT developers pursuing ONC certification: Applicable certification criteria can require identifying the relevant QMS and mapping it to recognized QMSes; this is a certification-specific context, not a rule that every health technology company follows the same regime.
- Clinical research organizations: Electronic-record expectations may apply to sponsors, investigators, IRBs, CROs and others using systems in clinical investigations. FDA’s clinical-investigation electronic systems Q&A is relevant to those operations, not a general eQMS purchasing rule.
Buying a platform neither makes an organization subject to a regulation nor proves that it has met one. Applicability depends on the business and activity; compliance depends on the organization’s implemented processes, controls and records.
What FDA’s QMSR means for device manufacturers in 2026
FDA’s Quality Management System Regulation became effective on February 2, 2026. It amends 21 CFR Part 820 and incorporates ISO 13485:2016 by reference. It is not accurate to say FDA replaced Part 820 with ISO: Part 820 remains the regulation’s location, and the FD&C Act and implementing regulations control if they conflict with the incorporated standard. See the FDA QMSR page for the agency’s description.
Rank #2
- Ideal for Gifting
- Ideal for a bookworm
- Compact for travelling
The effective date matters for records created earlier, too. For QMSR inspections on or after February 2, 2026, FDA may review QMS records created before that date. FDA also says it may inspect management review, quality audit and supplier audit reports; the former exception for those reports under the QS regulation is not maintained. The agency notes that a comparative analysis may help explain how pre-effective-date records meet QMSR requirements. These inspection points are set out in FDA’s QMSR FAQ.
For a company transitioning its processes or system, the practical implication is to preserve and be able to explain the history of existing records, rather than assuming only records created after the effective date matter. A software migration should not make earlier approvals, changes, investigations or audit evidence harder to retrieve or interpret.
Free tools Windows power users keep installed
One-click scans. No signup required.
How to choose QMS software for a medical-device company
Start with workflows and records, not a feature checklist from a vendor. Identify the quality processes in scope, who performs each one, what evidence must be retained, and how records connect to the product lifecycle. Then compare viable software and process options against the following criteria:
- Applicable scope: Which regulatory requirements or certification criteria apply to this organization, product and activity? Which quality processes must the system support?
- Process coverage: Assess the actual need for document control, training, nonconformance, CAPA, complaints, supplier controls, change control, and design and development records. “All-in-one” claims do not show that a workflow fits your procedures.
- Intended use and risk: Define what each workflow and record is used for and the consequences of an error, loss or unauthorized change. Those details inform the level of control and software assurance required.
- Record controls: Evaluate audit history, access controls, electronic approvals or signatures, retention, export and traceability against your procedures and obligations. A feature’s presence is not proof that its configuration or use is adequate.
- Configuration and integrations: Map the data and handoffs needed with design, issue-tracking, clinical, manufacturing or ERP systems. Include ownership of interfaces and how changes or failures will be managed.
- Usability and participation: Consider whether employees and relevant suppliers can complete the real workflows consistently. A system that is difficult to use can undermine the procedures it is meant to support.
- Migration and implementation: Plan how existing controlled documents and records will be transferred, checked, linked and retained. Account for configuration, integration, procedure updates, training and ongoing administration—not just subscription or license terms.
- Long-term ownership: Identify who will maintain procedures, user access, training, evidence and system changes after deployment. The organization must be able to sustain the controls it relies on.
These criteria are questions for evaluating a particular organization’s needs; they are not claims that every vendor offers every capability. Ask for demonstrations using representative workflows and records, and document why the selected approach is suitable for the intended use.
Rank #4
How to assure software used in production or the QMS
FDA’s final Computer Software Assurance guidance, dated February 2026, covers computers and automated data-processing systems used as part of medical-device production or the QMS. It recommends a risk-based approach to establish confidence in the software, decide where additional rigor is appropriate and select testing activities. The February 2026 guidance supersedes FDA’s September 24, 2025 final guidance.
Assurance is context-specific. A vendor’s validation package or test evidence can inform the work, but does not by itself establish that the customer’s intended use, configuration, integrations and procedures are adequately assured. The organization needs to assess its own use and risks, decide what evidence is appropriate, and retain a rationale for its conclusions.
PC Slower Than It Used to Be?
A free scan shows the junk files, broken settings and background clutter dragging Windows down - then fixes them in one click.Free scan · Windows 10 & 11Crashes, No Sound, or Screen Glitches?
Random freezes, missing sound and display glitches usually trace back to one bad driver. Find and replace yours safely.Free scan · under a minuteBest Value
- It can be a gift option
- Comes with secure packaging
- Helpful in various ways
ISO/TR 80002-2:2017 is a technical report on validation of software for medical-device quality systems. ISO describes its scope as software used in a QMS, production and service provision, and monitoring and measurement; it excludes software that is itself a medical device. See the ISO catalog entry. It can inform software-validation work, but does not replace applicable regulatory requirements or the organization’s own implementation.
Electronic records and signatures: when Part 11 matters
Do not assume every electronic quality record is subject to identical Part 11 controls. FDA’s Part 11 Scope and Application guidance describes the agency’s narrow interpretation of scope and recommends a documented risk assessment that considers predicate-rule obligations, possible effects on product quality and safety, and the integrity of required records and signatures.
Part 11 remains in effect, and FDA’s recommendations do not erase independent obligations under applicable predicate rules. The guidance also describes enforcement discretion for specified Part 11 audit-trail provisions while retaining predicate-rule requirements and recommending risk-based decisions. Determine which records and signatures are required for the specific activity, then document the basis for the controls chosen; do not infer that a software vendor’s “Part 11 compliant” label resolves that analysis.
Quick Recap
A practical decision sequence
- Establish the company’s regulatory and certification context. Identify products, intended uses, markets, business roles and certification plans that determine applicable obligations.
- Map the QMS before selecting a tool. Document processes, roles, records, approvals, interfaces and retention needs; note where existing manual or electronic processes create gaps.
- Decide which workflows need software support. Prioritize based on process risk, record needs, traceability and team capacity rather than digitizing every activity automatically.
- Compare options against defined use cases. Evaluate process fit, record controls, integration needs, usability, migration and ongoing ownership using representative scenarios.
- Plan implementation and assurance. Set responsibilities for configuration, testing, procedures, training, access, change control and evidence before relying on the system for quality decisions.
- Maintain evidence and revisit the rationale. Keep the records needed to show processes are followed and assess changes to products, systems, integrations or obligations for their effect on the QMS.
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
What’s actually slowing this PC down?
Pick the symptom - the matching free tool is one click away.
